Reduction of Intrathecal Immunoglobulin Levels with Ocrelizumab Treatment in Relapsing and Primary Progressive Multiple Sclerosis
MULTIPLE SCLEROSIS JOURNAL(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined